Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

An update on the use of helminths to treat Crohn's and other autoimmunune diseases.

Reddy A, Fried B.

Parasitol Res. 2009 Jan;104(2):217-21. doi: 10.1007/s00436-008-1297-5. Review.

PMID:
19050918
2.

Trichuris suis therapy in Crohn's disease.

Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV.

Gut. 2005 Jan;54(1):87-90.

3.

The use of Trichuris suis and other helminth therapies to treat Crohn's disease.

Reddy A, Fried B.

Parasitol Res. 2007 Apr;100(5):921-7. Review.

PMID:
17206504
4.

Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells.

Hiemstra IH, Klaver EJ, Vrijland K, Kringel H, Andreasen A, Bouma G, Kraal G, van Die I, den Haan JM.

Mol Immunol. 2014 Jul;60(1):1-7. doi: 10.1016/j.molimm.2014.03.003.

PMID:
24705296
5.

[Relevance of helminths in the prevention and healing of immune diseases].

ChacĂ­n-Bonilla L.

Invest Clin. 2009 Mar;50(1):1-4. Spanish.

PMID:
19418721
6.

Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?

Erb KJ.

Trends Immunol. 2009 Feb;30(2):75-82. doi: 10.1016/j.it.2008.11.005.

PMID:
19138565
7.

Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease.

Sandborn WJ, Elliott DE, Weinstock J, Summers RW, Landry-Wheeler A, Silver N, Harnett MD, Hanauer SB.

Aliment Pharmacol Ther. 2013 Aug;38(3):255-63. doi: 10.1111/apt.12366.

8.

A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors.

Croese J, O'neil J, Masson J, Cooke S, Melrose W, Pritchard D, Speare R.

Gut. 2006 Jan;55(1):136-7. No abstract available.

9.

Treating endometriosis as an autoimmune disease.

Nothnick WB.

Fertil Steril. 2001 Aug;76(2):223-31. Review.

PMID:
11476764
10.

Trichuris suis ova in inflammatory bowel disease.

Schölmerich J.

Dig Dis. 2013;31(3-4):391-5. doi: 10.1159/000354708. Review.

PMID:
24246995
11.

Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy.

Tilp C, Kapur V, Loging W, Erb KJ.

Int J Parasitol. 2013 Mar;43(3-4):319-25. doi: 10.1016/j.ijpara.2012.12.003. Review.

PMID:
23291462
12.

Iatrogenic Trichuris suis infection in a patient with Crohn disease.

Kradin RL, Badizadegan K, Auluck P, Korzenik J, Lauwers GY.

Arch Pathol Lab Med. 2006 May;130(5):718-20.

PMID:
16683891
14.

Biologic therapy in Crohn's disease: state of the art.

Jones J, Panaccione R.

Curr Opin Gastroenterol. 2008 Jul;24(4):475-81. doi: 10.1097/MOG.0b013e3283043596. Review.

PMID:
18622162
15.

Translatability of helminth therapy in inflammatory bowel diseases.

Weinstock JV, Elliott DE.

Int J Parasitol. 2013 Mar;43(3-4):245-51. doi: 10.1016/j.ijpara.2012.10.016. Review.

16.

Autoimmunity: The worm returns.

Weinstock JV.

Nature. 2012 Nov 8;491(7423):183-5. doi: 10.1038/491183a. No abstract available.

17.

Nutrition and Crohn's disease: an update of print and Web-based guidance.

Moorthy D, Cappellano KL, Rosenberg IH.

Nutr Rev. 2008 Jul;66(7):387-97. doi: 10.1111/j.1753-4887.2008.00048.x. Review.

PMID:
18667014
18.

Will worms really cure Crohn's disease?

Radford-Smith GL.

Gut. 2005 Jan;54(1):6-8. Review. No abstract available.

19.

Total parenteral nutrition in the management of Crohn's disease.

Descos L, Vignal J.

World J Surg. 1980;4(2):161-2. Review.

PMID:
6773250
20.

Enteral nutrition should be used to induce remission in childhood Crohn's disease.

Heuschkel R.

Dig Dis. 2009;27(3):297-305. doi: 10.1159/000228564. Review.

PMID:
19786755
Items per page

Supplemental Content

Support Center